ELSS Calculator
₹ 20,000 per month
1
Time period
6 months1 year3 year
Invested amount ₹ 3,30,00,000
Would have become
₹ 58,08,477
Tax Saving
Total Investment
Total Interest 
Mutual Fund Calculator
Monthly SIP Amount (₹)
Rate of Interest (% p.a.)
1
Time period (In years)
1
Total Invested 
Total Interest 
Total Amount after 5 years
1 Year Ret 0%
1Y
2Y
3Y
5Y
10Y
Fund Details
NAV
0
Sub-Type
Rating
Min. SIP Amount
0
Fund Age(Year)
124.47
Fund Size
0
Fund Performance
1 Month
0%
3 Month
0%
6 Month
0%
1 Year
0%
3 Year
0%
5 Year
0%
Know This Fund
As on 20 May 2024
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.

Comparison with same funds

Equity, Flexi Cap funds
Ret 1M
Ret 1Y
Ret 3Y
Ret 5Y
No items to show...
Charges & Taxes Expense Ratio
Expense Ratio (Inclusive of GST): 0%
Exit load  0%
Stamp Duty  0%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
AMC and Fund details
Rank (total sets)
0
Date of Incorporation
1900-01-01
Total AUM
1900-01-01

Latest News

Buy Shriram Pistons & Rings; target of Rs 2450: Emkay
Emkay's research report on Shriram Pistons & Rings. SPRL’s Q4 results were healthy, with consol. revenue/EBITDA/PAT growth of 22%/31%/27% YoY. SPRL’s 18% rev. growth was 2x the underlying auto industry’s. Mgmt guides for sustained outperformance ...
20 May 2024 | 05:54 PM

Buy PVR INOX; target of Rs 1650: Emkay
Emkay's research report on PVR INOX. PVR Inox’s Q4 results reflect the subpar performance of a weak movie lineup, sans any tentpole films. Footfalls, ATP, and SPH also saw a sequential decline owing to weak performance of movies and promotional offer...
20 May 2024 | 05:54 PM

Buy HPCL; target of Rs 600: Emkay
Emkay's research report on HPCL. HPCL’s Q4FY24 SA EBITDA was 11% lower than expected at Rs48.7bn, mainly due to lower cracks & discounts, MR shutdown, and intermediate stock generation impact (USD1-1.5/bbl), as reported GRM was USD7/bbl vs our es...
20 May 2024 | 05:52 PM

Buy Dr Lal Pathlabs; target of Rs 2800: Emkay
Emkay's research report on Dr Lal Pathlabs. DLPL posted a robust quarter, with revenue growing 11% YoY on the back of sample volume increasing 9% YoY and Swasthfit contributing 24% to the topline. DLPL’s focus and execution prowess on expanding its p...
20 May 2024 | 05:51 PM

Buy BPCL; target of Rs 730: Emkay
Emkay's research report on BPCL. BPCL clocked Q4FY24 EBITDA/APAT of Rs92.7/55.7bn – a sizable 17-18% beat each, driven by higher-than-expected implied marketing margin of ~Rs7/kg (at a 16% beat). BPCL’s reported GRM of USD12.5/bbl (vs. our estimate o...
20 May 2024 | 05:50 PM

Invest Now
ELSS Calculator
₹ 20,000 per month
1
Time period
6 months1 year3 year
Invested amount ₹ 3,30,00,000
Would have become
₹ 58,08,477
Tax Saving
Total Investment
Total Interest